Life-Sciences-UK.com
The British Life Sciences Web Portal

This is a free web portal for the life sciences in the UK and Ireland... » read more

eXmoor Pharma Completes $35m Series A Financing Round (2023-05-30)
New GMP facility to complete eXmoor’s transition from consultancy to one-stop global cell and gene therapy partner eXmoor pharma, the end-to-end cell and gene therapy (CGT) manufacturing partner, today announced the close of a $35 million Series A financing ro...
ElevateBio: $401m Series D Round Led by AyurMaya Capital (2023-05-24)
> Proceeds enable expansion and scale of ElevateBio’s cell and gene technology platforms, end-to-end capabilities, and therapeutic pipeline to serve an increasing number of biopharmaceutical partners and drive revenue growth > ElevateBio has added more than 15 n...
Renagade Therapeutics Launches with $300m Series A (2023-05-23)
> Company built on foundation of novel, proprietary delivery technologies and an integrated, multimodal, all-RNA platform to deliver, code, edit, and insert genetic information to correct disease > Financing led by biotechnology investors MPM BioImpact and F2 Ve...
Closed Loop Medicine Partners with Pharmanovia (2023-05-17)
> Pharmanovia’s leading medicine brands to be combined with Closed Loop Medicine’s technology to provide dose optimized personalized therapies > Global (ex-US) co-development and commercialization partnership to initially focus on next-generation drug + software...
CEBR Appoints New President and Vice-President (2023-05-17)
> CEBR celebrates its Board elections within the frame of its Annual Meeting 2023, taking place in Stuttgart on the 16th and 17th of May. > Forty representatives from the members’ organizations meet in Stuttgart to attend this key event for cluster managers. ...
H.E.L Group Makes Senior Management Appointments (2023-05-16)
> Hasan Hallaq, PhD appointed as European Sales Director, Victoria Ordsmith joins as Director of Marketing and Sarennah Longworth-Cook promoted Director of People > Appointments will help drive company growth and sales of H.E.L’s laboratory systems for the pharm...
Uniqure Sells Royalty Interest in Hemgenix for up to $400m (2023-05-15)
> uniQure to receive $375 million upfront cash payment > Under the existing agreement with CSL Behring, uniQure retains the rights to future milestones totaling up to $1.5 billion and maintains an interest in HEMGENIX® royalties > Capped royalty financing pro...
Nido Biosciences Emerges with $109n in Funding (2023-05-15)
Leveraging advancements in the understanding of human genetics and disease to develop a sustainable pipeline of novel precision medicines Nido Biosciences (Nido Bio), a clinical stage company developing precision medicines for debilitating neurological disease...
Ghent-based Dualyx Raises €40m to Progress Treg Therapies (2023-05-15)
> Use of proceeds will enable the development of the Company’s lead autoimmune program DT-001, targeting TNFR2, as well as its pipeline of Treg candidates > Financing co-led by Fountain Healthcare Partners, Forbion and Andera Partners with support from existing ...
Evonetix Delivers Chip-synthesized DNA to Univ Cambridge (2023-05-15)
> First delivery and use of DNA manufactured using Evonetix’s unique thermally controlled synthesis technology > Key milestone in the development of Evonetix’s desktop DNA synthesis platform EVONETIX LTD (‘Evonetix’), the company bringing semiconductor tech...

Life-Sciences-UK.com is your doorway to the British and Irish life sciences!

[LSUK] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the UK and Ireland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUK] is 100% Made in Germany!

» Start here with the latest News!

Picture Campus Berlin-Buch at BIO2023 Location of Future Innovation 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)